跳至主要内容
临床试验/ACTRN12621000142831
ACTRN12621000142831尚未招募2 期

Tissue Levels of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) and Effects on Perception and Personality in healthy volunteers

niversity of Western Australia0 个研究点目标入组 24 人开始时间: 2021年2月12日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 59 Years(—)
性别
All

入选标准

  • Healthy unmedicated people (with the exceptions of acne and contraceptive medications)

排除标准

  • pregnant or breast-feeding;
  • fertile, sexually active and not using contraceptives;
  • ingesting caffeine or any other stimulants on the day of each testing session;
  • using current prescription medications other than oral contraceptives or acne medication;
  • using over-the-counter medications or natural” therapies in the 48 hours before each testing session;
  • using recreational drugs including alcohol in the 48 hours before each testing session;
  • Any medical condition, including mental illness, requiring treatment other than acne;
  • a history of substance abuse disorder;
  • a family history in first degree relatives of any psychotic disorder (e.g., schizophrenia, bipolar disorder, schizoaffective disorder);
  • a history of sensitivity to cannabis (e.g., nausea, dizziness, anxiety).

研究者

发起方
niversity of Western Australia

相似试验